4.0 Review

Follow-up bone mineral density testing: 2023 official positions of the International Society for Clinical Densitometry

Journal

JOURNAL OF CLINICAL DENSITOMETRY
Volume 27, Issue 1, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jocd.2023.101440

Keywords

Osteoporosis; Bone mineral density; Dual-energy X-ray absorptiometry; Fracture risk; Aging; Monitoring

Ask authors/readers for more resources

Dual-energy X-ray absorptiometry (DXA) is the gold standard method for measuring bone mineral density (BMD), which is strongly associated with fracture risk. The International Society for Clinical Densitometry (ISCD) has released new official positions on follow-up DXA examinations, highlighting the importance of considering the clinical context and individualized testing intervals.
Dual-energy X-ray absorptiometry (DXA) is the gold standard method for measuring bone mineral density (BMD) which is most strongly associated with fracture risk. BMD is therefore the basis for the World Health Organization's densitometric definition of osteoporosis. The International Society for Clinical Densitometry (ISCD) promotes best densitometry practices and its official positions reflect critical review of current evidence by domain experts. This document reports new official positions regarding follow-up DXA examinations based on a systematic review of literature published through December 2022. Adoption of official positions requires consensus agreement from an expert panel following a modified RAND protocol. Unless explicitly altered by the new position statements, prior ISCD official positions remain in force. This update reflects increased consideration of the clinical context prompting repeat examination. Follow-up DXA should be performed with pre-defined objectives when the results would have an impact on patient management. Testing intervals should be individualized according to the patient's age, sex, fracture risk and treatment history. Incident fractures and therapeutic approach are key considerations. Appropriately ordered and interpreted follow-up DXA examinations support diagnostic and therapeutic decision making, thereby contributing to excellent clinical care. Future research should address the complementary roles of clinical findings, imaging and laboratory testing to guide management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available